Company Details
abbvie
58,020
1,735,135
3254
abbvie.com
571
ABB_1856359
Completed

AbbVie Company CyberSecurity Posture
abbvie.comAbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
Company Details
abbvie
58,020
1,735,135
3254
abbvie.com
571
ABB_1856359
Completed
Between 800 and 849

AbbVie Global Score (TPRM)XXXX

Description: The industrial behemoths Schneider Electric, werum.com, UCLA (http://ucla.edu), Abbie (http://abbvie.com), and Siemens Energy are among the five new MOVEit attacks victims listed on the dark web leak site for the Clop ransomware organization. Industrial Control Systems (ICS) are offered by Siemens Energy and Schneider Electric and are employed in crucial national infrastructures all over the world. Threat actors assert that by using the recently discovered MOVEit Transfer vulnerability CVE-2023-34362, they were able to breach 100 different businesses. Incentives are provided by the US government for intelligence that results in the capture, indictment, or location of threat actors.


No incidents recorded for AbbVie in 2025.
No incidents recorded for AbbVie in 2025.
No incidents recorded for AbbVie in 2025.
AbbVie cyber incidents detection timeline including parent company and subsidiaries

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.


Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Acc

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the pa

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneer

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (C

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently addre

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worl

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portf
.png)
Close-up of a laptop as AI News caught up with Rachel James, Principal. Share this story:.
Cencora, The Lash Group, and their affiliates have agreed to pay $40 million to settle class action data breach litigation over a February...
Over the past twelve months, AbbVie generated $56 billion in revenue, achieving an operating profit of $12 billion and a net income of $4.3...
The US Supreme Court is poised to provide important guidance on the PSLRA's particularity requirement in NVIDIA Corp. v. E. Ohman J:or Fonder AB, Case No. 23-...
ORMOND BEACH, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Health Information Sharing and Analysis Center (Health-ISAC), the non-profit...
Health-ISAC announces results of Board elections, reaffirming its role as a trusted global community for sharing cyber and physical security...
We believe that AbbVie stock (NYSE: ABBV) is currently a better pharmaceutical pick over Johnson & Johnson stock (NYSE: JNJ).
Fenwick is representing Aliada Therapeutics, a biotechnology company advancing therapies using a novel blood-brain barrier (BBB)-crossing technology.
The Golden Ticket Pitch Competition, offered by the American Cancer Society's BrightEdge in collaboration with AbbVie and Research Bridge...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of AbbVie is http://www.abbvie.com.
According to Rankiteo, AbbVie’s AI-generated cybersecurity score is 826, reflecting their Good security posture.
According to Rankiteo, AbbVie currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, AbbVie is not certified under SOC 2 Type 1.
According to Rankiteo, AbbVie does not hold a SOC 2 Type 2 certification.
According to Rankiteo, AbbVie is not listed as GDPR compliant.
According to Rankiteo, AbbVie does not currently maintain PCI DSS compliance.
According to Rankiteo, AbbVie is not compliant with HIPAA regulations.
According to Rankiteo,AbbVie is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
AbbVie operates primarily in the Pharmaceutical Manufacturing industry.
AbbVie employs approximately 58,020 people worldwide.
AbbVie presently has no subsidiaries across any sectors.
AbbVie’s official LinkedIn profile has approximately 1,735,135 followers.
AbbVie is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Yes, AbbVie has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/abbvie.
Yes, AbbVie maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/abbvie.
As of December 13, 2025, Rankiteo reports that AbbVie has experienced 1 cybersecurity incidents.
AbbVie has an estimated 5,425 peer or competitor companies worldwide.
Incident Types: The types of cybersecurity incidents that have occurred include Breach.
Detection and Response: The company detects and responds to cybersecurity incidents through an law enforcement notified with us government incentives for intelligence..
Title: MOVEit Transfer Vulnerability Exploited by Clop Ransomware
Description: The Clop ransomware organization has listed five new victims of MOVEit attacks on the dark web, including Schneider Electric, werum.com, UCLA, Abbie, and Siemens Energy. The threat actors claim to have breached 100 different businesses using the recently discovered MOVEit Transfer vulnerability CVE-2023-34362.
Type: Ransomware
Attack Vector: Exploitation of Vulnerability
Vulnerability Exploited: CVE-2023-34362
Threat Actor: Clop ransomware organization
Motivation: Financial gain
Common Attack Types: The most common types of attacks the company has faced is Breach.

Entity Name: Schneider Electric
Entity Type: Company
Industry: Industrial Control Systems
Location: Global

Entity Name: UCLA
Entity Type: Educational Institution
Industry: Education
Location: Los Angeles, CA

Entity Name: Siemens Energy
Entity Type: Company
Industry: Industrial Control Systems
Location: Global

Law Enforcement Notified: US government incentives for intelligence

Ransomware Strain: Clop
Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at and Source: UCLAUrl: http://ucla.edu, and Source: AbbieUrl: http://abbvie.com.
Last Attacking Group: The attacking group in the last incident was an Clop ransomware organization.
Most Recent Source: The most recent source of information about an incident are Abbie and UCLA.
Most Recent URL for Additional Resources: The most recent URL for additional resources on cybersecurity best practices is http://ucla.edu, http://abbvie.com .
.png)
LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, there is no handler for JSON parsing errors; SyntaxError from express.json() includes user input in the error message, which gets reflected in responses. User input (including HTML/JavaScript) can be exposed in error responses, creating an XSS risk if Content-Type isn't strictly enforced. This issue does not have a fix at the time of publication.
LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, when creating prompts, JSON requests are sent to define and modify the prompts via PATCH endpoint for prompt groups (/api/prompts/groups/:groupId). However, the request bodies are not sufficiently validated for proper input, enabling users to modify prompts in a way that was not intended as part of the front end system. The patchPromptGroup function passes req.body directly to updatePromptGroup() without filtering sensitive fields. This issue is fixed in version 0.8.1.
LibreChat is a ChatGPT clone with additional features. In versions 0.8.0 and below, when a user posts a question, the iconURL parameter of the POST request can be modified by an attacker. The malicious code is then stored in the chat which can then be shared to other users. When sharing chats with a potentially malicious “tracker”, resources loaded can lead to loss of privacy for users who view the chat link that is sent to them. This issue is fixed in version 0.8.1.
MaxKB is an open-source AI assistant for enterprise. Versions 2.3.1 and below have improper file permissions which allow attackers to overwrite the built-in dynamic linker and other critical files, potentially resulting in privilege escalation. This issue is fixed in version 2.4.0.
MaxKB is an open-source AI assistant for enterprise. In versions 2.3.1 and below, the tool module allows an attacker to escape the sandbox environment and escalate privileges under certain concurrent conditions. This issue is fixed in version 2.4.0.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.